Adeera Levin

Robert Allan Ltd, based in Vancouver, BC, is a renowned marine design firm specializing in innovative and diverse solutions across a range of platforms, including tugboats, ferries, and offshore support vessels. With a strong commitment to employee ownership, the company has build a reputation for its exceptional expertise in ship design, marine engineering, and consulting services. Established with a focus on advancing marine technology, Robert Allan Ltd effectively combines model-based structural design with cutting-edge practices to deliver superior vessels tailored to meet the needs of various maritime markets. Their extensive range of services encompasses everything from emergency response vessels to scientific research crafts, highlighting their versatility and dedication to excellence in marine design. Generated from the website

Emily Carr University of Art + Design is a prominent institution located in Vancouver, British Columbia, dedicated to fostering creativity and innovation in the fields of art and design. The university is situated on unceded traditional territories of the xʷməθkʷəy̓əm (Musqueam), Sḵwx̱wú7mesh (Squamish), and səl̓ílwətaʔ (Tsleil-Waututh) peoples. With a diverse range of programs and a commitment to research and community engagement, Emily Carr University aims to cultivate the next generation of artists and designers. The institution also emphasizes partnerships and collaboration, enhancing its role within the local and broader artistic community. Generated from the website

AbCellera is a biotechnology company based in Vancouver, British Columbia, that focuses on developing innovative antibody-based medicines through a unique platform integrating biology, computation, and engineering. With a growing team of over 600 professionals, the company aims to address significant challenges in healthcare by delivering first-in-class and best-in-class therapeutic solutions for various medical conditions. Since its inception, AbCellera has partnered with more than 40 collaborators on 100 antibody drug programs, demonstrating its commitment to pushing the limits of science and technology in medicine. The company's research pipeline includes promising candidates for treating conditions such as vasomotor symptoms associated with menopause and moderate-to-severe atopic dermatitis, reflecting its dedication to improving patient health and well-being. Generated from the website